Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tempest Therapeutics Inc (TPST)

Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tempest Therapeutics Inc 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 USA

www.tempesttx.com P: 415-798-8589

Description:

Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.

Key Statistics

Overview:

Market Capitalization, $K 70,349
Enterprise Value, $K 37,379
Shares Outstanding, K 22,192
Annual Sales, $ 0 K
Annual Net Income, $ -29,490 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,490 K
EBIT, $ -29,150 K
EBITDA, $ -28,770 K
60-Month Beta -1.76
% of Insider Shareholders 5.80%
% of Institutional Shareholders 22.52%
Float, K 20,905
% Float 94.20%
Short Volume Ratio 0.54

Growth:

1-Year Return 43.44%
3-Year Return -77.52%
5-Year Return -98.67%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.28%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 03/19/24
Latest Earnings Date 05/08/24
Earnings Per Share ttm -1.91
EPS Growth vs. Prev Qtr 29.17%
EPS Growth vs. Prev Year 46.03%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 06/28/21

TPST Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -283.87%
Return-on-Assets % -82.11%
Profit Margin % 0.00%
Debt/Equity 0.23
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.40
Book Value/Share 1.39
Interest Coverage -19.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar